At day 8 post infection, all mice in the IL-2 treated group (n = 8) had already cleared the virus in lung tissues while only 50% of the surviving mice in the PBS treated group had done so (Fig 2C), indicating enhanced anti-viral immunity. Here, IL2 is linked to infection.